{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T11:20:51Z","timestamp":1787656851042,"version":"build-2736575974"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T00:00:00Z","timestamp":1761350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T00:00:00Z","timestamp":1761350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00213-025-06935-3","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T04:27:40Z","timestamp":1761366460000},"page":"1877-1884","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Haloperidol\u2009\u2212\u2009norepinephrine synergy in stimulation of vacuous chewing movements in rats: Enhancement by nicotine"],"prefix":"10.1007","volume":"243","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1556-6707","authenticated-orcid":false,"given":"Ilya D.","family":"Ionov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria D.","family":"Krasilova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni\u0441holas P.","family":"Gorev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor I.","family":"Tulchinskiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey A.","family":"Gabov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita O.","family":"Lyubimova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyudmila I.","family":"Maltseva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr N.","family":"Komikarov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,25]]},"reference":[{"key":"6935_CR1","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.3181\/00379727-133-34713","volume":"133","author":"J Antunes-Rodrigues","year":"1970","unstructured":"Antunes-Rodrigues J, McCann SM (1970) Water, sodium chloride, and food intake induced by injections of cholinergic and adrenergic drugs into the third ventricle of the rat brain. Proc Soc Exp Biol Med 133:1464\u20131470. https:\/\/doi.org\/10.3181\/00379727-133-34713","journal-title":"Proc Soc Exp Biol Med"},{"key":"6935_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-019-0976-1","volume":"19","author":"D Arya","year":"2019","unstructured":"Arya D, Khan T, Margolius AJ, Fernandez HH (2019) Tardive dyskinesia: treatment update. Curr Neurol Neurosci Rep 19:69. https:\/\/doi.org\/10.1007\/s11910-019-0976-1","journal-title":"Curr Neurol Neurosci Rep"},{"key":"6935_CR3","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/0006-3223(87)90038-2","volume":"22","author":"RL Binder","year":"1987","unstructured":"Binder RL, Kazamatsuri H, Nishimura T, McNiel DE (1987) Smoking and tardive dyskinesia. Biol Psychiatry 22:1280\u20131282. https:\/\/doi.org\/10.1016\/0006-3223(87)90038-2","journal-title":"Biol Psychiatry"},{"key":"6935_CR4","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1124\/jpet.111.189100","volume":"340","author":"T Bordia","year":"2012","unstructured":"Bordia T, McIntosh JM, Quik M (2012) Nicotine reduces antipsychotic-induced orofacial dyskinesia in rats. J Pharmacol Exp Ther 340:612\u2013619. https:\/\/doi.org\/10.1124\/jpet.111.189100","journal-title":"J Pharmacol Exp Ther"},{"key":"6935_CR5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.expneurol.2016.09.009","volume":"286","author":"T Bordia","year":"2016","unstructured":"Bordia T, Zhang D, Perez XA, Quik M (2016) Striatal cholinergic interneurons and D2 receptor-expressing GABAergic medium spiny neurons regulate tardive dyskinesia. Exp Neurol 286:32\u201339. https:\/\/doi.org\/10.1016\/j.expneurol.2016.09.009","journal-title":"Exp Neurol"},{"key":"6935_CR6","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.16r10832","volume":"78","author":"M Carbon","year":"2017","unstructured":"Carbon M, Hsieh CH, Kane JM, Correll CU (2017) Tardive dyskinesia prevalence in the period of second-generation antipsychotic use: a meta-analysis. J Clin Psychiatry 78:e264\u2013e278. https:\/\/doi.org\/10.4088\/JCP.16r10832","journal-title":"J Clin Psychiatry"},{"key":"6935_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251810206","volume":"25","author":"S-M Chen","year":"2024","unstructured":"Chen S-M, Wang M-H, Chang K-C, Fang C-H, Lin Y-W, Tseng H-C (2024) Vitexin mitigates haloperidol-induced orofacial dyskinesia in rats through activation of the Nrf2 pathway. Int J Mol Sci 25:10206. https:\/\/doi.org\/10.3390\/ijms251810206","journal-title":"Int J Mol Sci"},{"key":"6935_CR8","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1139\/jpn.0323","volume":"28","author":"S-A Chong","year":"2003","unstructured":"Chong S-A, Tan E-C, Tan CH, Mythily (2003) Smoking and tardive dyskinesia: lack of involvement of the CYP1A2 gene. J Psychiatry Neurosci 28:185\u2013189","journal-title":"J Psychiatry Neurosci"},{"key":"6935_CR9","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.eplepsyres.2016.08.011","volume":"27","author":"CR de Carvalho","year":"2016","unstructured":"de Carvalho CR, Hoeller AA, Franco PLC, Martini APS, Soares FMS, Lin K, Prediger RD, Whalley BJ, Walz R (2016) The cannabinoid CB2 receptor-specific agonist AM1241 increases pentylenetetrazole-induced seizure severity in Wistar rats. Epilepsy Res 27:160\u2013167. https:\/\/doi.org\/10.1016\/j.eplepsyres.2016.08.011","journal-title":"Epilepsy Res"},{"key":"6935_CR10","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/0014-2999(92)90400-x","volume":"211","author":"M Diana","year":"1992","unstructured":"Diana M, Collu M, Mura A, Gessa GL (1992) Haloperidol-induced vacuous chewing in rats: suppression by alpha-methyl-tyrosine. Eur J Pharmacol 211:415\u2013419. https:\/\/doi.org\/10.1016\/0014-2999(92)90400-x","journal-title":"Eur J Pharmacol"},{"key":"6935_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.eurpsy.2008.07.007","volume":"24","author":"A Diehl","year":"2009","unstructured":"Diehl A, Reinhard I, Schmitt A, Mann K, Gattaz WF (2009) Does the degree of smoking effect the severity of tardive dyskinesia? A longitudinal clinical trial. Eur Psychiatry 24:33\u201340. https:\/\/doi.org\/10.1016\/j.eurpsy.2008.07.007","journal-title":"Eur Psychiatry"},{"key":"6935_CR12","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1111\/j.1476-5381.2011.01426.x","volume":"164","author":"S Duty","year":"2011","unstructured":"Duty S, Jenner P (2011) Animal models of Parkinson\u2019s disease: a source of novel treatments and clues to the cause of the disease. Br J Pharmacol 164:1357\u20131391. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01426.x","journal-title":"Br J Pharmacol"},{"key":"6935_CR13","doi-asserted-by":"publisher","first-page":"4280","DOI":"10.1073\/pnas.0400794101","volume":"101","author":"K Ebner","year":"2004","unstructured":"Ebner K, Rupniak NM, Saria A, Singewald N (2004) Substance P in the medial amygdala: emotional stress-sensitive release and modulation of anxiety-related behavior in rats. Proc Natl Acad Sci USA 101:4280\u20134285. https:\/\/doi.org\/10.1073\/pnas.0400794101","journal-title":"Proc Natl Acad Sci USA"},{"key":"6935_CR14","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s002130050095","volume":"127","author":"MF Egan","year":"1996","unstructured":"Egan MF, Hurd Y, Ferguson J, Bachus SE, Hamid EH, Hyde TM (1996) Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol. Psychopharmacology 127:337\u2013345. https:\/\/doi.org\/10.1007\/s002130050095","journal-title":"Psychopharmacology"},{"key":"6935_CR15","doi-asserted-by":"publisher","first-page":"e68231","DOI":"10.7759\/cureus.68231","volume":"16","author":"M Elnoor","year":"2024","unstructured":"Elnoor M, Bokhari SA, Singh M, Mohamed IA (2024) Effectiveness of vitamin E in treatment of antipsychotic-induced tardive dyskinesia and extrapyramidal symptoms: a case report. Cureus 16:e68231. https:\/\/doi.org\/10.7759\/cureus.68231","journal-title":"Cureus"},{"key":"6935_CR16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.parkreldis.2018.11.017","volume":"59","author":"K Frei","year":"2019","unstructured":"Frei K (2019) Tardive dyskinesia: who gets it and why. Parkinsonism Relat Disord 59:151\u2013154. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.11.017","journal-title":"Parkinsonism Relat Disord"},{"key":"6935_CR17","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1038\/sj.npp.1300975","volume":"31","author":"X-M Gao","year":"2006","unstructured":"Gao X-M, Cooper T, Suckow RF, Tamminga CA (2006) Multidose risperidone treatment evaluated in a rodent model of tardive dyskinesia. Neuropsychopharmacology 31:1864\u20131868. https:\/\/doi.org\/10.1038\/sj.npp.1300975","journal-title":"Neuropsychopharmacology"},{"key":"6935_CR18","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1600-0447.1988.tb05138.x","volume":"77","author":"J Gerlach","year":"1988","unstructured":"Gerlach J, Casey DE (1988) Tardive dyskinesia. Acta Psychiatr Scand 77:369\u2013378","journal-title":"Acta Psychiatr Scand"},{"key":"6935_CR19","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/j.1471-4159.2004.02574.x","volume":"90","author":"M Hamada","year":"2004","unstructured":"Hamada M, Higashi H, Nairn AC, Greengard P, Nishi A (2004) Differential regulation of dopamine D1 and D2 signaling by nicotine in neostriatal neurons. J Neurochem 90:1094\u20131103. https:\/\/doi.org\/10.1111\/j.1471-4159.2004.02574.x","journal-title":"J Neurochem"},{"key":"6935_CR20","doi-asserted-by":"publisher","first-page":"688","DOI":"10.9758\/cpn.24.1185","volume":"22","author":"K Irinaka","year":"2024","unstructured":"Irinaka K, Itoh Y, Yoshizawa K, Ogasawara M, Ayabe N, Mishima K, Takeshima M (2024) Successful electroconvulsive therapy for tardive dyskinesia and tardive dystonia refractory to valbenazine treatment: a case report and narrative literature review. Clin Psychopharmacol Neurosci 22:688\u2013696","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"6935_CR21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1192\/bjp.144.2.177","volume":"144","author":"DV Jeste","year":"1984","unstructured":"Jeste DV, Doongaji DR, Linnoila M (1984) Elevated cerebrospinal fluid noradrenaline in tardive dyskinesia. Br J Psychiatry 144:177\u2013180. https:\/\/doi.org\/10.1192\/bjp.144.2.177","journal-title":"Br J Psychiatry"},{"key":"6935_CR22","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/0006-3223(86)90245-3","volume":"21","author":"CA Kaufmann","year":"1986","unstructured":"Kaufmann CA, Jeste DV, Shelton RC, Linnoila M, Kafka MS, Wyatt RJ (1986) Noradrenergic and neuroradiological abnormalities in tardive dyskinesia. Biol Psychiatry 21:799\u2013812. https:\/\/doi.org\/10.1016\/0006-3223(86)90245-3","journal-title":"Biol Psychiatry"},{"key":"6935_CR23","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1176\/ajp.143.1.126b","volume":"143","author":"D Kemali","year":"1986","unstructured":"Kemali D, Maj M (1986) CSF noradrenaline and schizophrenia. Am J Psychiatry 143:126\u2013127. https:\/\/doi.org\/10.1176\/ajp.143.1.126b","journal-title":"Am J Psychiatry"},{"key":"6935_CR24","doi-asserted-by":"publisher","first-page":"201","DOI":"10.4140\/TCP.n.2018.201","volume":"33","author":"AP Kim","year":"2018","unstructured":"Kim AP, Baker DE, Levien TL (2018) VMAT2 inhibitors: new drugs for the treatment of tardive dyskinesia. Consult Pharm 33:201\u2013209","journal-title":"Consult Pharm"},{"key":"6935_CR25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2117903119","volume":"119","author":"K Kobayashi","year":"2022","unstructured":"Kobayashi K, Shikano K, Kuroiwa M, Horikawa M, Ito W, Nishi A, Segi-Nishida E, Suzuki H (2022) Noradrenaline activation of hippocampal dopamine D1 receptors promotes antidepressant effects. Proc Natl Acad Sci U S A 119:e2117903119. https:\/\/doi.org\/10.1073\/pnas.2117903119","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6935_CR26","doi-asserted-by":"publisher","DOI":"10.1126\/science.7350667","volume":"207","author":"CR Lake","year":"1980","unstructured":"Lake CR, Sternberg DE, van Kammen DP, Ballenger JC, Ziegler MG, Post RM, Kopin IJ, Bunney WE (1980) Schizophrenia: Elevated cerebrospinal fluid norepinephrine. Science 207:331\u2013333. https:\/\/doi.org\/10.1126\/science.7350667","journal-title":"Science"},{"key":"6935_CR27","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0006-8993(78)90595-4","volume":"149","author":"JA Meligeni","year":"1978","unstructured":"Meligeni JA, Ledergerber SA, McGaugh JL (1978) Norepinephrine attenuation of amnesia produced by diethyldithiocarbamate. Brain Res 149:155\u2013164. https:\/\/doi.org\/10.1016\/0006-8993(78)90595-4","journal-title":"Brain Res"},{"key":"6935_CR28","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0006-3223(96)00289-2","volume":"41","author":"A Nilsson","year":"1997","unstructured":"Nilsson A, Waller L, Rosengren A, Adlerberth A, Wilhelmsen L (1997) Cigarette smoking is associated with abnormal involuntary movements in the general male population - a study of men born in 1933. Biol Psychiatry 41:717\u2013723. https:\/\/doi.org\/10.1016\/S0006-3223(96)00289-2","journal-title":"Biol Psychiatry"},{"key":"6935_CR29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1211\/0022357021778358","volume":"54","author":"K Ossowska","year":"2002","unstructured":"Ossowska K (2002) Neuronal basis of neuroleptic-induced extrapyramidal side effects. Pol J Pharmacol 54:299\u2013312","journal-title":"Pol J Pharmacol"},{"key":"6935_CR30","volume-title":"The rat brain in stereotaxic coordinates","author":"G Paxinos","year":"1998","unstructured":"Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates. Academic, San Diego (CA)"},{"key":"6935_CR31","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/cvr\/cvp202","volume":"84","author":"J Peng","year":"2009","unstructured":"Peng J, Wang Y-K, Wang L-G, Yuan W-J, Su DF, Ni X, Deng XM, Wang W-Z (2009) Sympathoinhibitory mechanism of moxonidine: role of the inducible nitric oxide synthase in the rostral ventrolateral medulla. Cardiovasc Res 84:283\u2013291. https:\/\/doi.org\/10.1093\/cvr\/cvp202","journal-title":"Cardiovasc Res"},{"key":"6935_CR32","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s12640-024-00724-0","volume":"43","author":"R Ponciano","year":"2024","unstructured":"Ponciano R, Hallak JEC, Crippa JA, Guimar\u00e3es FS, Del Bel EA (2024) Cannabigerol mitigates haloperidol-induced vacuous chewing movements in mice. Neurotox Res 43:2. https:\/\/doi.org\/10.1007\/s12640-024-00724-0","journal-title":"Neurotox Res"},{"key":"6935_CR33","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/YPG.0000000000000258","volume":"30","author":"TJ Punchaichira","year":"2020","unstructured":"Punchaichira TJ, Kukshal P, Bhatia T, Deshpande SN, Thelma BK (2020) The effect of rs1076560 (DRD2) and rs4680 (COMT) on tardive dyskinesia and cognition in schizophrenia subjects. Psychiatr Genet 30:125\u2013135. https:\/\/doi.org\/10.1097\/YPG.0000000000000258","journal-title":"Psychiatr Genet"},{"key":"6935_CR34","doi-asserted-by":"publisher","first-page":"6826","DOI":"10.1007\/s12035-023-03496-4","volume":"60","author":"TJ Punchaichira","year":"2023","unstructured":"Punchaichira TJ, Kukshal P, Bhatia T, Deshpande SN, Thelma BK (2023) Effect of rs1108580 of DBH and rs1006737 of CACNA1C on cognition and tardive dyskinesia in a North Indian schizophrenia cohort. Mol Neurobiol 60:6826\u20136839. https:\/\/doi.org\/10.1007\/s12035-023-03496-4","journal-title":"Mol Neurobiol"},{"key":"6935_CR35","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jpsychires.2022.04.029","volume":"151","author":"L Qilin","year":"2022","unstructured":"Qilin L, Wang D, Zhou H, Chen D, Xiu M, Cui L, Zhang X (2022) Tardive dyskinesia in Chinese patients with schizophrenia: Prevalence, clinical correlates and relationship with cognitive impairment. J Psychiatr Res 151:181\u2013187. https:\/\/doi.org\/10.1016\/j.jpsychires.2022.04.029","journal-title":"J Psychiatr Res"},{"key":"6935_CR36","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.alcohol.2010.01.002","volume":"44","author":"ZA Rodd","year":"2010","unstructured":"Rodd ZA, Bell RL, Oster SM, Toalston JE, Pommer TJ, McBride WJ, Murphy JM (2010) Serotonin-3 receptors in the posterior ventral tegmental area regulate ethanol self-administration of alcohol-preferring (P) rats. Alcohol 44:245\u2013255. https:\/\/doi.org\/10.1016\/j.alcohol.2010.01.002","journal-title":"Alcohol"},{"key":"6935_CR37","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1124\/mol.115.101808","volume":"89","author":"M S\u00e1nchez-Soto","year":"2016","unstructured":"S\u00e1nchez-Soto M, Bonifazi A, Cai NS, Ellenberger MP, Newman AH, Ferr\u00e9 S, Yano H (2016) Evidence for noncanonical neurotransmitter activation: norepinephrine as a dopamine D2-like receptor agonist. Mol Pharmacol 89:457\u2013466. https:\/\/doi.org\/10.1124\/mol.115.101808","journal-title":"Mol Pharmacol"},{"key":"6935_CR38","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/s0196-9781(03)00045-7","volume":"24","author":"S Sharma","year":"2003","unstructured":"Sharma S, Paladino P, Gabriele J, Saeedi H, Henry P, Chang M, Mishra RK, Johnson RL (2003) Pro-leu-glycinamide and its peptidomimetic, PAOPA, attenuate haloperidol induced vacuous chewing movements in rat: a model of human tardive dyskinesia. Peptides 24:313\u2013319. https:\/\/doi.org\/10.1016\/s0196-9781(03)00045-7","journal-title":"Peptides"},{"key":"6935_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1092852917000621","volume":"23","author":"SM Stahl","year":"2018","unstructured":"Stahl SM (2018) Mechanism of action of vesicular monoamine transporter 2 (VMAT2) inhibitorsin tardive dyskinesia: reducing dopamine leads to less go and more stop from the motor striatumfor robust therapeutic effects. CNS Spectr 23:1\u20136. https:\/\/doi.org\/10.1017\/S1092852917000621","journal-title":"CNS Spectr"},{"key":"6935_CR40","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1176\/ajp.138.8.1045","volume":"38","author":"DE Sternberg","year":"1981","unstructured":"Sternberg DE, van Kammen DP, Lake CR, Ballenger JC, Marder SR, Bunney WE Jr (1981) The effect of Pimozide on CSF norepinephrine in schizophrenia. Am J Psychiatry 38:1045\u20131050. https:\/\/doi.org\/10.1176\/ajp.138.8.1045","journal-title":"Am J Psychiatry"},{"key":"6935_CR41","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/BF00451690","volume":"98","author":"AJ Stoessl","year":"1989","unstructured":"Stoessl AJ, Dourish CT, Iversen SD (1989) Chronic neuroleptic-induced mouth movements in the rat: suppression by CCK and selective dopamine D1 and D2 receptor antagonists. Psychopharmacology 98:372\u2013379. https:\/\/doi.org\/10.1007\/BF00451690","journal-title":"Psychopharmacology"},{"key":"6935_CR42","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0091-3057(93)90329-r","volume":"46","author":"K Suemaru","year":"1993","unstructured":"Suemaru K, Gomita Y, Furuno K, Araki Y (1993) Chronic nicotine treatment potentiates behavioral responses to dopaminergic drugs in rats. Pharmacol Biochem Behav 46:135\u2013139. https:\/\/doi.org\/10.1016\/0091-3057(93)90329-r","journal-title":"Pharmacol Biochem Behav"},{"key":"6935_CR43","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/s0149-7634(02)00008-8","volume":"26","author":"P Turrone","year":"2002","unstructured":"Turrone P, Remington G, Nobrega JN (2002) The vacuous chewing movement (VCM) model of tardive dyskinesia revisited: is there a relationship to dopamine D2 receptor occupancy? Neurosci Biobehav Rev 26:361\u2013380. https:\/\/doi.org\/10.1016\/s0149-7634(02)00008-8","journal-title":"Neurosci Biobehav Rev"},{"key":"6935_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2021.102877","volume":"66","author":"K Uludag","year":"2021","unstructured":"Uludag K, Wang DM, Goodman C, Chen DC, Wang L, Zhang X (2021) Prevalence, clinical correlates and risk factors associated with tardive dyskinesia in Chinese patients with schizophrenia. Asian J Psychiatr 66:102877. https:\/\/doi.org\/10.1016\/j.ajp.2021.102877","journal-title":"Asian J Psychiatr"},{"key":"6935_CR45","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1038\/npp.2012.81","volume":"37","author":"AA Williams","year":"2012","unstructured":"Williams AA, Ingram WM, Levine S, Resnik J, Kamel CM, Lish JR, Elizalde DI, Janowski SA, Shoker J, Kozlenkov A, Gonz\u00e1lez-Maeso J, Gallitano AL (2012) Reduced levels of serotonin 2A receptors underlie resistance of Egr3-deficient mice to locomotor suppression by clozapine. Neuropsychopharmacology 37:2285\u20132298. https:\/\/doi.org\/10.1038\/npp.2012.81","journal-title":"Neuropsychopharmacology"},{"key":"6935_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00427414","volume":"83","author":"P Willner","year":"1984","unstructured":"Willner P (1984) The validity of animal models of depression. Psychopharmacology 83:1\u201316. https:\/\/doi.org\/10.1007\/BF00427414","journal-title":"Psychopharmacology"},{"key":"6935_CR47","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0006-8993(85)90442-1","volume":"348","author":"K Yamanaka","year":"1985","unstructured":"Yamanaka K, Oshita M, Muramatsu I (1985) Alteration of alpha and muscarinic receptors in rat brain and heart following chronic nicotine treatment. Brain Res 348:241\u2013248. https:\/\/doi.org\/10.1016\/0006-8993(85)90442-1","journal-title":"Brain Res"},{"key":"6935_CR48","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0006-3223(87)90131-4","volume":"22","author":"R Yassa","year":"1987","unstructured":"Yassa R, Lal S, Korpassy A, Ally J (1987) Nicotine exposure and tardive dyskinesia. Biol Psychiatry 22:67. https:\/\/doi.org\/10.1016\/0006-3223(87)90131-4","journal-title":"Biol Psychiatry"},{"issue":"S1","key":"6935_CR49","doi-asserted-by":"publisher","first-page":"S391","DOI":"10.1016\/j.eurpsy.2017.02.442","volume":"41","author":"L Zouari","year":"2017","unstructured":"Zouari L, Smaoui N, Abida I, Charfi N, Ma\u00e2lej M, Zouari N, Ben Thabet J, Ma\u00e2lej M (2017) Smoking and tardive dyskin Esia in patients with schizophrenia. Eur Psychiatry 41(S1):S391\u2013S392. https:\/\/doi.org\/10.1016\/j.eurpsy.2017.02.442","journal-title":"Eur Psychiatry"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-025-06935-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-025-06935-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-025-06935-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T10:40:30Z","timestamp":1787654430000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-025-06935-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,25]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["6935"],"URL":"https:\/\/doi.org\/10.1007\/s00213-025-06935-3","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,25]]},"assertion":[{"value":"12 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflicts of interests to declare.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All applicable international, national, and institutional guidelines for the care and use of animals were followed. The experiments were conducted in accordance with the European Communities Council Directive 2010\/63\/EU. The experimental protocol was approved by the Ethics Committee for the Use and Care of Laboratory Animals of the Centre on Theoretical Problems in Physical and Chemical Pharmacology (# A11\/19012022\/4).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable for that specific section.","order":3,"name":"Ethics","label":"Consent to participate\u00a0and publish","group":{"name":"EthicsHeading","label":"Declarations"}}]}}